31927 - Workshop Session Two - Regulatory Expectations and Strategy for Design of In-use Stability Studies

Speaker(s):

• Isabella de Jong, Genentech
• Danielle Leiske, Seagen
• Jing Liu, Seagen Inc.
• Jennifer Swisher, CDER, FDA
• Camellia Zamiri, Genentech, a Member of the Roche Group